Overview 
Day 1
Day 2
Register 
PDF Download 
Posters  
Hotel & Travel 
Sponsor 
Press Pass 
Request Brochure 

HELD DIRECTLY FOLLOWING THE

Seventh Annual
Systems Integration in Biodefense
August 18-19, 2008

and Prior to the

Inaugural
Future of Cancer Diagnostics:
Next Generation Molecular Technologies

August 21-22, 2008

 Science AAAS

Bio-IT World

The Scientist

BioSpace

Biolexis

PharmCast

 

Strategic Review of Point-of-Care Diagnostics

by Scientia Advisors

 

FILLING THE TECHNOLOGY GAPS

Featured Presentation

Keith WardTechnical Hurdles Facing Homeland Security Bio-Countermeasures Development
Keith Ward, Program Manager, Department of Homeland Security

 

 

 

Boris NikolicLeveraging Cell Phone Technology to Make Point-of-Care Diagnostics Accessible in the Developing World
Boris Nikolic, M.D., Senior Program Officer, Bill & Melinda Gates Foundation

 

 

 

Steven GutmanEXPERT PANEL: Regulatory Guidance and Reimbursement Issues
Steven I. Gutman, M.D., Director, Office of in Vitro Diagnostic Device Evaluation and Safety, Food & Drug Administration

 

 

 

Paul RadenskyPaul Radensky, M.D., J.D., Partner, McDermott Will & Emery LLP

 

 


 

Thomas Gustafson

Thomas A. Gustafson, Ph.D., Senior Policy Advisor, Arnold & Porter, LLP

 


 

Scientific Advisory Board 
Stanley Abramowitz, Advanced Technology Group, LLC
John C. Carrano, Ph.D., Vice President, Research and Development, Luminex Corporation
Shuqi Chen, Ph.D., Chief Executive Officer, IQuum, Inc.
Carol A. Dahl, Ph.D., Chief of Staff, Global Health Program, Director, Global Health Discovery, Bill & Melinda Gates Foundation
Harry Glorikian, Managing Partner, Scientia Advisors
Brenda J. Korte, Ph.D., Program Director, Discovery Science & Technology, National Institute of Biomedical Imaging and BioEngineering, NIH
Matthew Lorence, Ph.D., M.B.A., Vice President, Marketing and Sales, Tessarae, LLC
Lucy Lu, Ph.D.

Held Directly Following the
Seventh Annual
Systems Integration in Biodefense • August 18-19, 2008
www.healthtech.com/btr/overview.aspx

and Prior to the
Inaugural
Future of Cancer Diagnostics:
Next Generation Molecular Technologies
• August 21-22, 2008
www.healthtech.com/cdx/overview.aspx